AIG
RNAC icon

American International Group’s Cartesian Therapeutics RNAC Stock Holding History

American International Group’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,873
Closed -$36.5K – 2165
2024
Q1 		$36.5K Sell
1,873
-74
-4% -$1.57K ﹤0.01% 2849
2023
Q4 		$40.3K Buy
1,947
+15
+0.8% +$448 ﹤0.01% 2862
2023
Q3 		$61.4K Buy
1,932
+69
+4% +$2.31K ﹤0.01% 2764
2023
Q2 		$62.6K Buy
+1,863
New +$66.7K ﹤0.01% 2821
2022
Q2 		– Sell
-1,523
Closed -$56K – 3237
2022
Q1 		$56K Sell
1,523
-108
-7% -$6.76K ﹤0.01% 2809
2021
Q4 		$159K Sell
1,631
-26
-2% -$2.8K ﹤0.01% 2500
2021
Q3 		$207K Sell
1,657
-11
-0.7% -$1.33K ﹤0.01% 2415
2021
Q2 		$209 Buy
1,668
+351
+27% +$41.8K ﹤0.01% 2477
2021
Q1 		$179 Buy
1,317
+3
+0.2% +$372 ﹤0.01% 2424
2020
Q4 		$119 Sell
1,314
-38
-3% -$3.29K ﹤0.01% 2568
2020
Q3 		$101K Sell
1,352
-30
-2% -$2.3K ﹤0.01% 2534
2020
Q2 		$118K Buy
+1,382
New +$125K ﹤0.01% 2423
2019
Q2 		– Sell
-727
Closed -$52K – 3147
2019
Q1 		$52K Buy
727
+332
+84% +$21K ﹤0.01% 2864
2018
Q4 		$32K Sell
395
-3
-0.8% -$685 ﹤0.01% 2971
2018
Q3 		$186K Buy
398
+7
+2% +$2.81K ﹤0.01% 2469
2018
Q2 		$155K Buy
391
+91
+30% +$32.3K ﹤0.01% 2517
2018
Q1 		$92K Sell
300
-13
-4% -$3.7K ﹤0.01% 2698
2017
Q4 		$92K Buy
313
+51
+19% +$22.3K ﹤0.01% 2764
2017
Q3 		$143K Buy
262
+20
+8% +$10.6K ﹤0.01% 2469
2017
Q2 		$144K Buy
242
+138
+133% +$61K ﹤0.01% 2485
2017
Q1 		$45K Buy
+104
New +$43.8K ﹤0.01% 2863

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

American International Group's RNAC Position: Q2 2024 in Review

American International Group sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 1,873 shares — an estimated $36.5K sold.

American International Group first reported a position in RNAC in Q1 2017 and held it in 21 quarters. The position peaked at $207K in Q3 2021. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • American International Group reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,873 Cartesian Therapeutics shares in Q2 2024, an estimated $36.5K.
  • American International Group first reported a position in Cartesian Therapeutics in Q1 2017 and held it in 21 quarters.
  • American International Group's Cartesian Therapeutics position peaked at $207K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.